The harm of fine particulate matter (PM2. 5) to public health is the focus of attention around
the world. The Global Burden of Disease (GBD) Study 2015 ranked PM2. 5 as the fifth …

Mounting evidence suggests that air pollution contributes to the large global burden of
respiratory and allergic diseases, including asthma, chronic obstructive pulmonary disease …

Air pollution and climate change are potential drivers for the increasing burden of allergic
diseases. The molecular mechanisms by which air pollutants and climate parameters may …

The novel coronavirus disease (COVID-19) is primarily respiratory in nature, and as such,
there is interest in examining whether air pollution might contribute to disease susceptibility …

Chronic obstructive pulmonary disease (COPD) is a common airway disorder. In particular,
acute exacerbations of COPD (AECOPD) can significantly reduce pulmonary function. The …

In order to better understand how ambient air particulate matter (PM) affect lung health, the
two main airway cell types likely to interact with inhaled particles, alveolar macrophages …

With the rapid growth of the nanotechnology industry, the need to understand the biological
effects of aerosol exposure has become increasingly important. Featuring contributions by …

The use of cerium compounds as diesel fuel catalyst results in the emission of cerium oxide
nanoparticles (CeO2) in the exhaust. This study characterized the potential effects of CeO2 …

Although the potential human health impacts from exposure to engineered nanoparticles
(ENPs) are uncertain, past epidemiological studies have established correlations between …

Nanoscale CeO2 is increasingly used for industrial and commercial applications, including
catalysis, UV-shielding and as an additive in various nanocomposites. Because of its …